文献速递乳腺癌支持与姑息治疗

美国肿瘤内科医生对非裔美国乳腺癌患者遗传咨询与检测认知的全国调查

Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
PubMed 文献 · J Clin Oncol · 2021-10-18

该研究对美国乳腺肿瘤内科医生进行49项全国性调查,评估其对不同种族患者遗传咨询与检测(GCT)的知识、态度和实践差异。277名医生中仅1.8%表示更倾向转诊白人患者,但66.9%认为非裔美国女性GCT率更低,63.4%认为其面临更多障碍,58.1%认为缺乏信任是非裔美国女性更大的障碍(P<.0001)。结论提示医生感知障碍存在种族差异,需教育干预以减少偏见、改善GCT公平性。

要点

  • 多数医生认识到非裔美国乳腺癌患者GCT率更低且面临更多障碍。
  • 医生感知缺乏信任和不依从是非裔美国女性更大的GCT障碍。
  • 需针对医生偏见开展教育和干预以促进GCT公平。

核心结论

  • 肿瘤内科医生对乳腺癌患者GCT感知障碍存在种族差异,需教育干预以减少偏见并改善非裔美国女性GCT公平性。

研究设计与样本

  • 美国全国性49项问卷调查,对象为乳腺肿瘤内科医生,共277名受访者(女性58.8%,肿瘤内科医生75.1%,学术机构医生61.7%,白人67.1%)。

主要发现

  • 仅1.8%的医生表示更可能转诊白人患者而非非裔美国患者进行GCT。
  • 66.9%的医生认为非裔美国乳腺癌女性GCT率低于白人女性。
  • 63.4%的医生认为非裔美国女性面临比白人女性更多的GCT障碍。
  • 21%的医生认为非裔美国女性在GCT决策过程中需要更多信息和指导。
  • 58.1%的医生认为缺乏信任是非裔美国女性更大的障碍(P<.0001),30.6%认为非裔美国女性更可能不依从GCT(P<.0001)。

临床怎么用

  • 临床医生应意识到自身对非裔美国乳腺癌患者GCT的潜在偏见,并主动优化转诊与沟通。
  • 针对感知障碍(如信任和不依从)开展患者教育和共享决策,以促进GCT公平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine if physicians' self-reported knowledge, attitudes, and practices regarding genetic counseling and testing (GCT) vary by patients' race. METHODS: We conducted a nationwide 49-item survey among breast oncology physicians in the United States. We queried respondents about their own demographics, clinical characteristics, knowledge, attitudes, practices, and perceived barriers in providing GCT to patients with breast cancer. RESULTS: Our survey included responses from 277 physicians (females, 58.8%; medical oncologists, 75.1%; academic physicians, 61.7%; and Whites, 67.1%). Only 1.8% indicated that they were more likely to refer a White patient than refer an African American patient for GCT, and 66.9% believed that African American women with breast cancer have lower rates of GCT than White women. Regarding perceived barriers to GCT, 63.4% of respondents indicated that African American women face more barriers than White women do and 21% felt that African American women require more information and guidance during the GCT decision-making process than White women. Although 32% of respondents indicated that lack of trust was a barrier to GCT in all patients, 58.1% felt that this was a greater barrier for African American women (P < .0001). Only 13.9% believed that noncompliance with GCT is a barrier for all patients, whereas 30.6% believed that African American women are more likely than White women to be noncompliant (P < .0001). CONCLUSION: We demonstrated that racial differences exist in oncology physicians' perceived barriers to GCT for patients with breast cancer. This nationwide survey will serve as a basis for understanding physicians' determinants of GCT for African American women and highlights the necessity of education and interventions to address bias among physicians. Awareness of such physician biases can enable further work to address inequities, ultimately leading to improved GCT equity for African American women with breast cancer.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Ademuyiwa FO, Salyer P, Tao Y, et al. Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists. J Clin Oncol. 2021. PMID: 34662201. doi:10.1200/JCO.21.01426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。